Pdt Partners, LLC Travere Therapeutics, Inc. Transaction History
Pdt Partners, LLC
- $1.01 Billion
- Q1 2024
A detailed history of Pdt Partners, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 195,541 shares of TVTX stock, worth $1.61 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
195,541
Previous 61,521
217.84%
Holding current value
$1.61 Million
Previous $553,000
172.51%
% of portfolio
0.15%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.5MCall Options Held
66.9KPut Options Held
265K-
Black Rock Inc. New York, NY7.8MShares$64.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$61.7 Million0.79% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$60.6 Million1.88% of portfolio
-
State Street Corp Boston, MA6.61MShares$54.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.27MShares$51.5 Million0.0% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $528M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...